Neoadjuvant, Adjuvant, or Both? The Debate in NSCLC Rages On Neoadjuvant, Adjuvant, or Both? The Debate in NSCLC Rages On
The question of whether to give upfront immunochemotherapy in resectable non –small cell lung cancer, wait until after surgery, or give both remains a hot topic of debate.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Hematology | Lung Cancer | Neoadjuvant Therapy | Non-Small Cell Lung Cancer